Ajayi Samuel, Raji Yemi, Bello Temitope, Arije Ayodeji
Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria.
University College Hospital, Ibadan, Oyo State, Nigeria.
Pan Afr Med J. 2020 Apr 28;35:138. doi: 10.11604/pamj.2020.35.138.21066. eCollection 2020.
Peritoneal dialysis is a form of renal replacement therapy that is both effective and relatively affordable. Peritoneal dialysis (PD) was first used in Nigeria as a treatment option for renal failure. Its use was first reported in Nigeria in 1969 and became more widespread in the 80s and 90s. Haemodialysis, which is capital intensive to set up and requires infrastructures and facilities such as electricity, intense water consumption and buildings, seems to have upstaged peritoneal dialysis both in demand and supply.
This cross-sectional study is a convenient survey of nephrologists, renal technicians and nurses in Nigeria. We used a structured, self-administered questionnaire on a cross-section of members and associate members attending a national nephrology association meeting.
There were 68(54.4%) doctors, 43(27.2%) nurses, and 14(11.2%) renal technicians, all from medical institutions with renal treatment programs who participated in the study. The most common problems encountered with PD use are financial constraints (51.7%), inadequate fluid supply (50%), frequent line blockage (22.4%) and frequent infections (17.2%). Reasons attributed to the stoppage of PD in the centres included lack of PD fluids (50.8%), unavailability of PD catheters (22.8%), lack of expert personnel to train (15.8%).
Main challenges to peritoneal dialysis use in Nigeria include limited experience and training and availability and cost of consumables. Effort to overcome the factors militating against its use should be positively pursued so that peritoneal dialysis will be re-integrated into the mainstream of renal replacement therapy once more.
腹膜透析是一种有效且相对经济的肾脏替代治疗方式。腹膜透析(PD)最初在尼日利亚被用作肾衰竭的治疗选择。1969年首次在尼日利亚有其使用的报道,并在80年代和90年代更为广泛地应用。血液透析建立成本高昂,需要电力、大量用水及建筑等基础设施和设备,在需求和供应方面似乎都已超越了腹膜透析。
这项横断面研究是对尼日利亚肾病学家、肾脏技术员和护士进行的一项便利调查。我们对参加全国肾脏病协会会议的会员和准会员使用结构化的自填问卷。
共有68名(54.4%)医生、43名(27.2%)护士和14名(11.2%)肾脏技术员参与了研究,他们均来自设有肾脏治疗项目的医疗机构。腹膜透析使用中最常见的问题是资金限制(51.7%)、液体供应不足(50%)、频繁的管路堵塞(22.4%)和频繁感染(17.2%)。各中心腹膜透析停用的原因包括缺乏腹膜透析液(50.8%)、无法获得腹膜透析导管(22.8%)、缺乏专家人员进行培训(15.8%)。
尼日利亚腹膜透析使用的主要挑战包括经验和培训有限以及耗材的可获得性和成本。应积极努力克服阻碍其使用的因素,以便腹膜透析能够再次重新融入肾脏替代治疗的主流。